| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458369A1 Gel comprising at least a retinoid and benzoyl peroxide |
| 09/22/2004 | EP1458358A1 Stable topical formulation of clarithromycin |
| 09/22/2004 | EP1458350A2 Talc-containing cosmetic cleansing emulsion |
| 09/22/2004 | EP1458349A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458347A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458342A1 Cosmetic and dermatological light-protective formulations comprising hydroxybenzophenones and benzoxazole derivatives |
| 09/22/2004 | EP1458337A1 Stable surfactant compositions for suspending components |
| 09/22/2004 | EP1458334A1 Yeast-based curative and care product and method for making same |
| 09/22/2004 | EP1373298B1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same |
| 09/22/2004 | EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 09/22/2004 | EP1272154B1 Composition for improving skin lipid barrier function |
| 09/22/2004 | EP1268475B1 Novel benzosultam oxazolidinone antibacterial agents |
| 09/22/2004 | EP1259598B1 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1152743B1 Skin sanitizing compositions |
| 09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1140860B1 Pyrimidine compounds |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP0967969B1 Novel antioxidant mixture |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531442A Perylenequinones for use as photosensitizers and sonosensitizers |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/22/2004 | CN1531435A Methods for inhibiting angiogenesis |
| 09/22/2004 | CN1531433A Synergistic pharmaceutical combination for prevention or treatment of diabetes |
| 09/22/2004 | CN1531430A Local used composition containing antifungal agent |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1531419A In-situ gel formation of pectins |
| 09/22/2004 | CN1530132A Tianfang xifeng huagu pillets |
| 09/22/2004 | CN1530130A Quebanjing for freckles |
| 09/22/2004 | CN1530115A Chinese medicine composition for deep fungus infection |
| 09/22/2004 | CN1530111A Antipruritic |
| 09/22/2004 | CN1167707C 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167684C Non-ball shaped and non-flake type mercapto pyridine oxide salts and prepn. method therefor |
| 09/22/2004 | CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d |
| 09/22/2004 | CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/22/2004 | CN1167466C Oral medicinal preparation |
| 09/22/2004 | CN1167455C Medicine for acne and its preparation |
| 09/22/2004 | CN1167451C External applied medicine for scald and burn, and its production and use |
| 09/22/2004 | CN1167437C Medicine for curing heloma and planter wart |
| 09/22/2004 | CN1167433C Medicine for treating acne and its preparing process |
| 09/22/2004 | CN1167430C Broad-spectrum antibacterial ointment for treating deep burn |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/22/2004 | CN1167413C Aerosol ointment compositions and preparation thereof |
| 09/22/2004 | CN1167409C Cosmetic compositions containing mulberry extract and retinoids |
| 09/22/2004 | CN1167358C Nutritional composition for treating pressure ulcers |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794380 Amide derivatives |
| 09/21/2004 | US6794178 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 09/21/2004 | US6794137 Detecting exposure of a cell to ultraviolet radiation; obtain cells, screen for preferential gene expression, monitor cells for adjusted tubulin protein expression |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/16/2004 | WO2004078758A1 Novel fused heterocycles and uses thereof |
| 09/16/2004 | WO2004078723A1 Novel compound having 4-pyridylalkylthio group as substituent |
| 09/16/2004 | WO2004078719A1 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 09/16/2004 | WO2004078695A1 Method for the purification of crocetin |
| 09/16/2004 | WO2004078213A1 Composition for target substance introduction and method of target substance introduction |
| 09/16/2004 | WO2004078199A1 Treatment of chronic chalazion and hordeolum with botulinum toxin |
| 09/16/2004 | WO2004078188A1 COMPOSITION CONTAINING β-GLUCAN AND CONSTIPATION-RELIEVING DRUG, IMMUNOPOTENTIATOR AND SKIN MOISTENING AGENT USING THE COMPOSITION |
| 09/16/2004 | WO2004078186A1 Ointment preparation for repairing injured skin |
| 09/16/2004 | WO2004078185A1 Method of transdermal and transmucosal absorption of carbon dioxide and cosmetic method and therapeutic method |
| 09/16/2004 | WO2004078122A2 Invisible patch for active agnet controlled delivery |
| 09/16/2004 | WO2004045609A3 Hydroxypyridinones for the local treatment of skin microcirculatory disorders |
| 09/16/2004 | WO2003105776A3 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 09/16/2004 | WO2003065971A3 Non-myeloablative tolerogenic treatment with tyrphostins |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003045228A9 Methods for treating autoimmune disorders, and reagents related thereto |
| 09/16/2004 | WO2003043583A3 Treatment of immunological disorders using anti-cd30 antibodies |
| 09/16/2004 | WO2002050097A3 Anti-allergic complex molecules |
| 09/16/2004 | US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040180930 excellent suppressing effect to cell injury caused by radicals and neurotoxicity induced by excitatory nuerotransmitters such as glutamate |
| 09/16/2004 | US20040180914 5-Cyano-2-aminopyrimidine derivatives |
| 09/16/2004 | US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable |
| 09/16/2004 | US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 09/16/2004 | US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/16/2004 | US20040180881 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine |
| 09/16/2004 | US20040180876 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis |
| 09/16/2004 | US20040180853 Allantoin-containing skin cream |
| 09/16/2004 | US20040180850 Polysaccharides with Helicobacter pylori receptor activity; preventing bacteria adhesion; stabilizing gastrointestinal mucus layer against ulcer causing agents |
| 09/16/2004 | US20040180836 Blocking peptide for inflammatory cell secretion |
| 09/16/2004 | US20040180832 Sustained peptide-release formulation |